logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Statistical bulletin 2007 search results

Statistics found here the keyword is opioids

Category Title
HSR HSR-7. Estimated number of clients in methadone treatment and of clients receiving any opioid substitution in EU-27 and Norway, 2003 and 2005
HSR HSR-3. Number of opioid maintenance treatment clients as rate per 100 of the estimated number of problem opioid users, 2004 and 2005
TDI TDI-4. Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2005 or most recent year available Part (ii) Primary drug type used (percent of new clients using) and of those, the percent injecting it
TDI TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2005 or most recent year available Part (ii) Primary drug type used by clients (percent of all clients) and of those, the percent injecting it
TDI TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2005 or most recent year available Part (v) Primary drug type used by male clients (percent of all male clients)
TDI TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2005 or most recent year available Part (vi) Primary drug type used by female clients (percent of all female clients)
TDI TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 Part (i) Distribution of new outpatient clients by age group for each primary drug
TDI TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 Part (ii) Distribution of new outpatient clients by primary drug for each age group
TDI TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 Part (iii) Distribution of all outpatient clients by age group for each primary drug
TDI TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 Part (iv) Distribution of all outpatient clients by primary drug for each age group
TDI TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 Part (v) Distribution of new inpatient clients by age group for each primary drug
TDI TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 Part (vi) Distribution of new inpatient clients by primary drug for each age group
TDI TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 Part (vii) Distribution of all inpatient clients by age group for each primary drug
TDI TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 Part (viii) Distribution of all inpatient clients by primary drug for each age group
TDI TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 Part (i) Distribution of new outpatient clients by age group for each primary drug
TDI TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 Part (ii) Distribution of new outpatient clients by primary drug for each age group
TDI TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 Part (iii) Distribution of all outpatient clients by age group for each primary drug
TDI TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 Part (iv) Distribution of all outpatient clients by primary drug for each age group
TDI TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 Part (v) Distribution of new inpatient clients by age group for each primary drug
TDI TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 Part (vi) Distribution of new inpatient clients by primary drug for each age group
TDI TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 Part (vii) Distribution of all inpatient clients by age group for each primary drug
TDI TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 Part (viii) Distribution of all inpatient clients by primary drug for each age group
TDI TDI-17. Route of administration of primary drug as main reason for asking treatment among new and all outpatient clients in 2005 Part (i) Percentage amongst new clients with opioids as primary drug
TDI TDI-17. Route of administration of primary drug as main reason for asking treatment among new and all outpatient clients in 2005 Part (v) Percentage amongst all clients with opioids as primary drug
TDI TDI-18. Frequency of use of primary drug among new and all outpatient and inpatient clients in 2005 Part (i) Percentage distribution amongst new outpatient clients
TDI TDI-18. Frequency of use of primary drug among new and all outpatient and inpatient clients in 2005 Part (ii) Percentage distribution amongst all outpatient clients
TDI TDI-18. Frequency of use of primary drug among new and all outpatient and inpatient clients in 2005 Part (iii) Percentage distribution amongst new inpatient clients
TDI TDI-18. Frequency of use of primary drug among new and all outpatient and inpatient clients in 2005 Part (iv) Percentage distribution amongst all inpatient clients
TDI TDI-19. New and all clients entering outpatient and inpatient treatment: distribution (percentage) by primary drug at treatment in 2005 for those countries supplying data Part (i) New clients entering outpatient treatment
TDI TDI-19. New and all clients entering outpatient and inpatient treatment: distribution (percentage) by primary drug at treatment in 2005 for those countries supplying data Part (ii) All clients entering outpatient treatment
TDI TDI-19. New and all clients entering outpatient and inpatient treatment: distribution (percentage) by primary drug at treatment in 2005 for those countries supplying data Part (iii) New clients entering inpatient treatment
TDI TDI-19. New and all clients entering outpatient and inpatient treatment: distribution (percentage) by primary drug at treatment in 2005 for those countries supplying data Part (iv) All clients entering inpatient treatment
TDI TDI-21. Gender ratio by primary drug - ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2005 for countries supplying data Part (i) Gender ratio (ratio of males to females) among new clients entering outpatient treatment
TDI TDI-21. Gender ratio by primary drug - ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2005 for countries supplying data Part (ii) Gender ratio (ratio of males to females) among all clients entering outpatient treatment
TDI TDI-21. Gender ratio by primary drug - ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2005 for countries supplying data Part (iii) Gender ratio (ratio of males to females) among new clients entering inpatient treatment
TDI TDI-21. Gender ratio by primary drug - ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2005 for countries supplying data Part (iv) Gender ratio (ratio of males to females) among all clients entering inpatient treatment
TDI TDI-22. Secondary drugs: number of citations by all clients in outpatient and inpatient centres in 2005: average for those EU countries supplying data Part (ii) Inpatient centres
TDI TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2005: the combination of opioids, cocaine, cannabis or other stimulants as primary drug type with a secondary drug Part (i) Most frequent combination of the primary drug with the stated types of secondary drug (percentages)
TDI TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2005: the combination of opioids, cocaine, cannabis or other stimulants as primary drug type with a secondary drug Part (ii) All clients with opioids as primary drug type: number of episodes reporting the stated drugs as secondary
TDI TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2005: the combination of opioids, cocaine, cannabis or other stimulants as primary drug type with a secondary drug Part (iii) All clients with cocaine as primary drug type: number of episodes reporting the stated drugs as secondary
TDI TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2005: the combination of opioids, cocaine, cannabis or other stimulants as primary drug type with a secondary drug Part (iv) All clients with cannabis as primary drug: number of episodes reporting the stated drug as secondary
TDI TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2005: the combination of opioids, cocaine, cannabis or other stimulants as primary drug type with a secondary drug Part (v) All clients with stimulants other than cocaine as primary drug type: number of episodes reporting the stated drugs as secondary
TDI TDI-24. All and new clients entering outpatient and inpatient treatment centres by main drug for which they ask for treatment in 2005 for those countries supplying data Part(i) All clients entering treatment by percentage of Outpatient and Inpatient treatment
TDI TDI-24. All and new clients entering outpatient and inpatient treatment centres by main drug for which they ask for treatment in 2005 for those countries supplying data Part(ii) New clients entering treatment by percentage of Outpatient and Inpatient treatment
TDI TDI-25. Age distribution (column percentage) by gender among all clients entering outpatient treatment with primary drug: opioids, cocaine, stimulants and cannabis in 2005 for countries supplying data
TDI TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2005 for those countries supplying data Part (i) Number of clients using opioids as primary drug
TDI TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2005 for those countries supplying data Part (i) Number of clients using opioids as primary drug
TDI TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2005 for those countries supplying data Part (i) Number of clients using opioids as primary drug
TDI TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2005 for those countries supplying data Part (i) Number of clients using opioids as primary drug
TDI TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2005 for those countries supplying data Part (i) Number of clients using opiates as primary drug
TDI TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2005 for those countries supplying data Part (i) Number of clients using opiates as primary drug
TDI TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2005 for those countries supplying data Part (i) Number of clients using opiates as primary drug
TDI TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2005 for those countries supplying data Part (i) Number of clients using opiates as primary drug
TDI TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2005 Part (i) Percentage distribution amongst new clients with opioids as primary drug
TDI TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2005 Part (ii) Percentage distribution amongst all clients with opioids as primary drug
TDI TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2005 Part (i) Percentage distribution amongst new clients with opioids as primary drug
TDI TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2005 Part (ii) Percentage distribution amongst all clients with opioids as primary drug
TDI TDI-114. All and new clients entering treatment for opioids by type of opioid misused for countries supplying data in 2005 Part(i) Percentage among all clients entering treatment for opioids use from all clients entering treatment
TDI TDI-114. All and new clients entering treatment for opioids by type of opioid misused for countries supplying data in 2005 Part (ii) Percentage among new clients entering treatment for opioids use from all new clients entering treatment
TDI TDI-114. All and new clients entering treatment for opioids by type of opioid misused for countries supplying data in 2005 Part (iii) Number and percentage among all clients entering treatment
TDI TDI-114. All and new clients entering treatment for opioids by type of opioid misused for countries supplying data in 2005 Part(iv) Number and percentage among new client entering treatment
TDI TDI-118. Polydrug use with cocaine among all clients entering outpatient treatment, for countries supplying data for 2005 Part (ii) All clients with cocaine HCl as primary drug type: numbers of episodes reporting the stated drugs as secondary
TDI TDI-118. Polydrug use with cocaine among all clients entering outpatient treatment, for countries supplying data for 2005 Part (iii) All clients with crack as primary drug type: number of episodes reporting the stated drugs as secondary
TDI TDI-118. Polydrug use with cocaine among all clients entering outpatient treatment, for countries supplying data for 2005 Part (iv) All clients with opioids as primary drug type: number of episodes reporting cocaine HCl and crack as secondary
TDI TDI-119. Percentage proportion of all clients treated on opioid misuse from all treated clients within the treatment centres by type of treatment centre for countries supplying data in 2005
TDI TDI-122. All outpatient clients under 15 entering treatment by primary drug in 2005 for those countries supplying data
TDI TDI-125. Primary drug of consumption among all drug clients under 15 entering drug treatment in 2005 in 6 EU countries + Turkey

Page last updated: Tuesday, 20 March 2012